Posterior echo enhancement was not associated with a poor BCSS in luminal and HER2 + ve cancers (93% vs. 95% 6 year survival, p = 0.84 and 78% vs. 88% 6 year survival, p = 0.2, respectively). The gene discussed is ERBB2; the disease is cancer.